Loading clinical trials...
Loading clinical trials...
COGNIKET-MCI Trial: A Prospective, Randomized, Double-blind, Placebo-controlled, Multi-center, Multi-country, Pivotal Trial to Study the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides (kMCT) and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment
Conditions
Interventions
BrainXpert
Placebo
Locations
30
United States
Stein Gerontological Institute Inc
Miami, Florida, United States
University of Rochester
Rochester, New York, United States
Hôpital Pierre Wertheimer
Bron, France
CHU de Montpellier - Hôpital Gui de Chauliac
Montpellier, France
CHU de Nantes - Hôpital Nord Laennec
Nantes, France
CHU de Toulouse - Gerontopole
Toulouse, France
Start Date
May 24, 2024
Primary Completion Date
December 15, 2027
Completion Date
December 15, 2027
Last Updated
August 14, 2025
NCT07220668
NCT04123314
NCT06780917
NCT07449117
NCT07101380
NCT07420426
Lead Sponsor
Société des Produits Nestlé (SPN)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions